Drug recall D-0825-2021
Product
Zonisamide Capsules USP 50 mg 100 Capsules Rx Only NDC 68462-129-01 Manufactured by: Glenmark Pharmaceuticals Inc., USA Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430
Reason for recall
CGMP Deviations
Lots and codes
Lots: 29190043 Exp. 05/31/2022; 29190044 Exp. 05/31/2022; 29190045 Exp. 05/31/2022
Recall details
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ
- Quantity
- 15936 bottles
- Distribution
- Nationwide.
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 27, 2021
- Terminated
- October 4, 2023
Related products
- Zonisamide – drug information
- NDC 68462-130 Zonisamide · Zonisamide 100 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-129 Zonisamide · Zonisamide 50 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-128 Zonisamide · Zonisamide 25 mg/1 · Glenmark Pharmaceuticals Inc., USA